Myovant Enterprise Value over EBITDA Trend from 2010 to 2021

Myovant Sciences Enterprise Value over EBITDA yearly trend continues to be fairly stable with very little volatility. Enterprise Value over EBITDA will likely drop to -6.6 in 2021. During the period from 2010 to 2021, Myovant Sciences Enterprise Value over EBITDA regression line of quarterly data had mean square error of 1.77 and geometric mean of  5.93. Myovant Sciences Research and Development Expense is fairly stable at the moment as compared to the past year. Myovant Sciences reported Research and Development Expense of 136.71 Million in 2020. Selling General and Administrative Expense is likely to climb to about 195.7 M in 2021, whereas Earning Before Interest and Taxes EBIT is likely to drop (263.7 M) in 2021.

Search Historical Trends 

 
Refresh
Check Myovant Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Myovant main balance sheet or income statement drivers, such as Cost of Revenue of 269.3 K, Gross Profit of 52.8 M or Interest Expense of 10.4 M, as well as many exotic indicators such as Asset Turnover of 0.12, Current Ratio of 2.92 or Free Cash Flow per Share of 4.42. Myovant financial statements analysis is a perfect complement when working with Myovant Sciences Valuation or Volatility modules. It can also supplement various Myovant Sciences Technical models. Check out Stocks Correlation.

Myovant Enterprise Value over EBITDA Breakdown

Showing smoothed Enterprise Value over EBITDA of Myovant Sciences with missing and latest data points interpolated. Measures the ratio between [EV] and [EBITDAUSD].Myovant Sciences' Enterprise Value over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Myovant Sciences' overall financial position and show how it may be relating to other accounts over time.
Enterprise Value over EBITDA10 Years Trend
Increasing
Stable
 Enterprise Value over EBITDA 
Share
      Timeline 

Myovant Enterprise Value over EBITDA Regression Statistics

Arithmetic Mean(6.10)
Geometric Mean 5.93
Coefficient Of Variation(21.03)
Mean Deviation 0.58
Median(6.17)
Standard Deviation 1.28
Sample Variance 1.64
Range 5.87
R-Value 0.14
Mean Square Error 1.77
R-Squared 0.018861
Significance 0.67
Slope 0.048821
Total Sum of Squares 18.07

Myovant Enterprise Value over EBITDA History

2017 (8.50) 
2018 (6.09) 
2019 (2.63) 
2020 (6.12) 
2021 (6.60) 

Myovant Sciences Investors Sentiment

The influence of Myovant Sciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Myovant. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - MYOV

Myovant Sciences Investor Sentiment

Most of Macroaxis users are now bullish on Myovant Sciences. What is your trading attitude regarding investing in Myovant Sciences? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Myovant Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Stocks Correlation. Note that the Myovant Sciences information on this page should be used as a complementary analysis to other Myovant Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Tools for Myovant Stock

When running Myovant Sciences price analysis, check to measure Myovant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myovant Sciences is operating at the current time. Most of Myovant Sciences' value examination focuses on studying past and present price action to predict the probability of Myovant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Myovant Sciences' price. Additionally, you may evaluate how the addition of Myovant Sciences to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go